FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-4.94%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$662M
AUM Growth
+$662M
(-8.2%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-3.27%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
81
New
8
Increased
13
Reduced
33
Closed
10
Top Buys
| 1 |
Insmed
INSM
|
$22.8M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20.5M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$13.9M |
| 4 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
$10.7M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$9.63M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$56.2M |
| 2 |
Nektar Therapeutics
NKTR
|
$25.4M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$14.1M |
| 4 |
Viatris
VTRS
|
$11M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$5.79M |
Sector Composition
| 1 | Healthcare | 72.38% |
| 2 | Communication Services | 8.27% |
| 3 | Industrials | 1.62% |
| 4 | Energy | 0.92% |
| 5 | Financials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tandem Diabetes Care
TNDM
$834M
| $8.04M | 1.22% |
136,328
-537
| -0.4% | -$31.7K |
|
27
Ultragenyx Pharmaceutical
RARE
$3.04B
| $7.69M | 1.16% |
179,659
-358
| -0.2% | -$15.3K |
|
28
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.98M | 1.06% |
103,552
+33,475
| +48% | +$2.26M |
|
29
Teva Pharmaceuticals
TEVA
$21.5B
| $6.67M | 1.01% |
969,230
-3,004
| -0.3% | -$20.7K |
|
|
LHCG
30
DELISTED
LHC Group LLC
LHCG
| $6.07M | 0.92% |
53,479
-574
| -1% | -$65.2K |
|
31
Bristol-Myers Squibb
BMY
$96.7B
| $5.87M | 0.89% |
115,700
-49,697
| -30% | -$2.52M |
|
32
Bio-Techne
TECH
$8.3B
| $5.52M | 0.83% |
28,226
-265
| -0.9% | -$51.9K |
|
|
CSII
33
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.03M | 0.76% |
105,856
-83,176
| -44% | -$3.95M |
|
34
Ligand Pharmaceuticals
LGND
$3.25B
| $4.94M | 0.75% |
49,578
-49,071
| -50% | -$4.88M |
|
35
Trupanion
TRUP
$1.9B
| $4.9M | 0.74% |
192,797
-1,981
| -1% | -$50.4K |
|
36
Takeda Pharmaceutical
TAK
$47.8B
| $4.87M | 0.74% |
283,200
-131,427
| -32% | -$2.26M |
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $4.51M | 0.68% |
26,615
-263
| -1% | -$44.6K |
|
38
Simulations Plus
SLP
$289M
| $4.34M | 0.66% |
125,012
-128,518
| -51% | -$4.46M |
|
39
OrthoPediatrics
KIDS
$524M
| $4.3M | 0.65% |
122,016
-1,244
| -1% | -$43.9K |
|
|
40
Viatris
VTRS
$12.3B
| $3.72M | 0.56% |
188,290
-555,494
| -75% | -$11M |
|
41
QuidelOrtho
QDEL
$1.87B
| $3.34M | 0.5% |
54,369
-574
| -1% | -$35.2K |
|
|
TLGT
42
DELISTED
Teligent, Inc
TLGT
| $3.05M | 0.46% |
3,213,936
-13,067
| -0.4% | -$12.4K |
|
|
KDNY
43
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.65M | 0.4% |
2,497,022
-1,120,631
| -31% | -$1.19M |
|
|
ALXN
44
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.62M | 0.4% |
26,698
-222
| -0.8% | -$21.7K |
|
45
Q32 Bio
QTTB
$20.9M
| $2.58M | 0.39% |
+142,449
| New | +$2.58M |
|
46
Alkermes
ALKS
$4.95B
| $2.4M | 0.36% |
123,107
-104,916
| -46% | -$2.05M |
|
47
iShares Biotechnology ETF
IBB
$5.68B
| $2.11M | 0.32% |
21,248
| – | – |
|
|
EPZM
48
DELISTED
Epizyme, Inc
EPZM
| $2.04M | 0.31% |
198,059
-2,004
| -1% | -$20.7K |
|
49
Invesco S&P SmallCap Health Care ETF
PSCH
$145M
| $1.96M | 0.3% |
17,285
| – | – |
|
50
iShares US Medical Devices ETF
IHI
$4.27B
| $1.87M | 0.28% |
7,580
| – | – |
|